KLK4 and non-small cell lung carcinoma: Several studies have suggested that the key to using kallikreins as biomarkers is to test them in combination; in fact, for colorectal, ovarian, and non-small cell lung cancer, kallikreins are more effective as multiparameter panels of biomarkers than as individual antigens.